RU2002126880A - METHOD FOR CYTOGENETIC CONTROL OF SKIN MELANOMA THERAPY - Google Patents

METHOD FOR CYTOGENETIC CONTROL OF SKIN MELANOMA THERAPY

Info

Publication number
RU2002126880A
RU2002126880A RU2002126880/15A RU2002126880A RU2002126880A RU 2002126880 A RU2002126880 A RU 2002126880A RU 2002126880/15 A RU2002126880/15 A RU 2002126880/15A RU 2002126880 A RU2002126880 A RU 2002126880A RU 2002126880 A RU2002126880 A RU 2002126880A
Authority
RU
Russia
Prior art keywords
cytogenetic
control
skin melanoma
therapy
melanoma therapy
Prior art date
Application number
RU2002126880/15A
Other languages
Russian (ru)
Inventor
Александр Степанович Монахов
Алексей Степанович Барчук
Валентин Вадимович Анисимов
Original Assignee
НИИ онкологии им. проф. Н.Н. Петрова
Filing date
Publication date
Application filed by НИИ онкологии им. проф. Н.Н. Петрова filed Critical НИИ онкологии им. проф. Н.Н. Петрова
Publication of RU2002126880A publication Critical patent/RU2002126880A/en

Links

Claims (1)

Способ цитогенетического контроля терапии меланомы кожи, отличающийся тем, что цитогенетическое исследование проводят на лимфоцитах периферической крови больных до начала лечения, через сутки и через месяц после каждого курса терапии, затем через каждые 3 месяца в первый год после окончания назначенного лечения и ежегодно.A method of cytogenetic control of therapy for skin melanoma, characterized in that a cytogenetic study is performed on peripheral blood lymphocytes of patients before treatment, one day and one month after each course of therapy, then every 3 months in the first year after the end of the prescribed treatment and annually.
RU2002126880/15A 2002-10-07 METHOD FOR CYTOGENETIC CONTROL OF SKIN MELANOMA THERAPY RU2002126880A (en)

Publications (1)

Publication Number Publication Date
RU2002126880A true RU2002126880A (en) 2004-04-20

Family

ID=

Similar Documents

Publication Publication Date Title
DE69624907D1 (en) ORAL PHARMACEUTICAL PHARMACEUTICAL PHARMACEUTICAL FORMS CONTAINING A PROTON PUMP INHIBITOR AND ANTACIDUM OR ALGINATE
DE69822199D1 (en) MEDICAMENT AND METHOD FOR TREATING ATTENTION FAILURES AND ATTENTION / HYPERACTIVITY DISORDERS WITH METHYLPHENIDATE
CA2292533A1 (en) Method and system for incrementally moving teeth
DE69524614D1 (en) MEDICINAL COMPONENTS, INCLUDING AN N-SUBSTITUTED O-TOLUIDE INDEXIVATIVE AND TRANSDERMALLY ABSORBABLE PREPARATION
DK1178783T3 (en) Device and use for enhancing the transdermal permeation of drugs
DE60303244D1 (en) An implantable cardiac stimulating device and system comprising this device
ATE181422T1 (en) METHOD FOR DIAGNOSIS OF PREECLAMPSIA
WO2004006849A3 (en) Combinations of drugs for the treatment of neoplasms
DE69935743D1 (en) Active implantable medical device, in particular multi-digit cardiac stimulator, defibrillator and / or cardioverter
RU2002126880A (en) METHOD FOR CYTOGENETIC CONTROL OF SKIN MELANOMA THERAPY
NO890997L (en) APPLICATOR FOR SKIN CARE, SKIN CARE AND MEDICAL SALVATION.
PT1496884E (en) ASSOCIATION OF ANTITROMBOTIC AND ASPIRIN AND THEIR USE IN THE TREATMENT OF ATEROSCLEROSIS TROMBOTIC DISEASES.
DE19714710A1 (en) Pad applying medicament to the anal region in case of e.g. haemorrhoids
RU2002118186A (en) METHOD FOR TREATING MASTOPATHY
RU2005129591A (en) METHOD FOR TREATING CHRONIC HEART FAILURE
RU2004113429A (en) METHOD FOR THE TREATMENT OF VISUAL FATIGUE IN COMPUTER USERS
RU2003100546A (en) METHOD FOR TREATING MASTOPATHY
RU2002130727A (en) METHOD FOR TREATING CHILDREN AND ADOLESCENTS WITH LATENT TUBERCULOSIS INFECTION
ITRM920165A1 (en) USE OF L-CARNITINE IN THE TREATMENT OF HIV-SEROPOSITIVE PATIENTS PRESENTING CARNITINE DEFICIT.
RU94034142A (en) METHOD FOR NON-MEDICINAL TREATMENT OF PATIENTS WITH PSYCHOLOGICAL-VEGETATIVE DISORDERS
RU2003109140A (en) METHOD FOR STOPPING BLEEDING IN WOMEN DURING PERENAUSE
WO2007067753A3 (en) Methods of reducing side effects in cancer therapy
RU2003120877A (en) METHOD FOR TREATING LUNG TUBERCULOSIS
RU2002126955A (en) METHOD FOR TREATING MASTOPATHY
RU2002117250A (en) METHOD FOR TREATING VIRAL KERATOUVEITS